ReachMD

Popular

• • 

    

    Kevin Brown, MD

    Peer

  • 

    

    Kevin R. Flaherty, MD

    Peer

  • 

    

    Rebecca C. Keith, MD

    Peer

  2

  

  RestartResume

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  1.00 credits

• • 

    

    Kevin Garey, PharmD, MS

    Peer

  • 

    

    A. Krishna Rao, MD, MS

    Peer

  7

  

  RestartResume

  The Changing Landscape of Clostridioides difficile Infections

  0.25 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Gregory S. Sawicki, MD, MPH

    Peer

  2

  

  RestartResume

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  0.25 credits

• • 

    

    Anita L. Nelson, MD

    Peer

  • 

    

    David J. Portman, MD

    Peer

  7

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs

  0.25 credits

• • 

    

    Rishi P. Singh, MD

    Peer

  • 

    

    Sophie J. Bakri, MD

    Peer

  • 

    

    Dilsher S. Dhoot, MD

    Peer

  • 

    

    David Eichenbaum, MD

    Peer

  6

  

  RestartResume

  Managing COVID-19 Related Delays In Patients with Neovascular AMD

  1.00 credits

• • 

    

    Linda Bernstein, Pharm.D.

    Peer

  3

  

  RestartResume

  CDC Playbook for COVID-19 Vaccine Distribution

• • 

    

    Pradeep Y. Ramulu, MD, PhD

    Peer

  • 

    

    E. Randy Craven, MD

    Peer

  • 

    

    Mark T. Dunbar, OD, FAAO

    Peer

  4

  

  RestartResume

  Innovations in Glaucoma Therapy

  0.25 credits

• • 

    

    Charles Daley, MD

    Peer

  • 

    

    Shannon H. Kasperbauer, MD

    Peer

  1

  

  RestartResume

  Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

  1.00 credits

• • 

    

    Yehuda Handelsman, MD

    Peer

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  • 

    

    Om P. Ganda, MD

    Peer

  • 

    

    Jorge Plutzky, MD

    Peer

  • 

    

    Paul D. Rosenblit, MD, PhD, FACE, FNLA

    Peer

  2

  

  RestartResume

  Hot Topics in Omega-3s and ASCVD Risk Reduction in Diabetes

  2.50 credits

• • 

    

    Eric Simpson, MD, MCR

    Peer

  • 

    

    Jonathan I. Silverberg, MD, PhD, MPH

    Peer

  0

  

  RestartResume

  Understanding the Pathophysiology of Atopic Dermatitis: Have We Only Scratched the Surface?

• • 

    

    Eric Simpson, MD, MCR

    Peer

  • 

    

    Jonathan I. Silverberg, MD, PhD, MPH

    Peer

  3

  

  RestartResume

  Exploring the Patient Experience in Atopic Dermatitis: Burden and Impact of Disease

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  4

  

  RestartResume

  Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lawrence F. Eichenfield, MD

    Peer

  • 

    

    Linda Stein Gold, MD

    Peer

  3

  

  RestartResume

  Moderate-to-Severe Atopic Dermatitis: Expert Insights on Late-Breaking Data in Systemic Treatment

  0.25 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Sandeep Nathan, MD

    Peer

  5

  

  RestartResume

  Dual Pathway Inhibition: A Different Antithrombotic Strategy for Patients With CAD/PAD

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  3

  

  RestartResume

  Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know